Jianjun Zhao

Assistant Staff
Cancer Biology
Cleveland Clinic Lerner Research Institute
United States of America

Professor Medicine
Biography

Zhao investigates the role of proteins and non-coding RNAs in the initiation of multiple myeloma (MM), with the goal of designing new therapeutic strategies for MM.

Research Intrest

Multiple myeloma, tumor initiation, microRNA, novel therapy, drug delivery, drug resistance

List of Publications
Liu S, An J, Lin J, Liu Y, Bao L, Zhang W, Zhao JJ. Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma. Plos One. 2014 Mar 27;9(3):e92791.
Zhao JJ, Carrasco DR (2014)Crosstalk between microRNA-30s and the Wnt pathway: Implications for cancer therapy. Cancer Research. Oct 1;74(19):5351-5358.
Zhao JJ, et al. (2015) Targeting the miR-221-222/PUMA/BAK/BAX pathway abrogates dexamethasone resistance in multiple myeloma. Cancer Research. Aug 6. pii: canres.0457.2015